PHARM-SYS LTD 12749673 false 2022-08-01 2023-07-31 2023-07-31 The principal activity of the company is general medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 12749673 2022-08-01 2023-07-31 12749673 2023-07-31 12749673 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 12749673 bus:Micro-entities 2022-08-01 2023-07-31 12749673 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 12749673 bus:FilletedAccounts 2022-08-01 2023-07-31 12749673 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 12749673 bus:RegisteredOffice 2022-08-01 2023-07-31 12749673 bus:Director1 2022-08-01 2023-07-31 12749673 bus:Director2 2022-08-01 2023-07-31 12749673 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 12749673 countries:AllCountries 2022-08-01 2023-07-31 12749673 2021-08-01 2022-07-31 12749673 2022-07-31 12749673 core:CurrentFinancialInstruments core:WithinOneYear 2022-07-31 iso4217:GBP xbrli:pure

Registration number: 12749673

PHARM-SYS LTD

Unaudited Filleted Financial Statements

for the Year Ended 31 July 2023

 

PHARM-SYS LTD

Contents

Company Information

1

Statement of financial position

2 to 3

Notes to the Unaudited Financial Statements

2

 

PHARM-SYS LTD

Company Information

Directors

Mr M R Jillings

Mrs J Jillings

Registered office

11 King's Street
Kings Lynn
Norfolk
PE30 1ET

Accountants

Hayhow & Co.
Chartered Certified Accountants & Business Advisers
19 King Street
King's Lynn
Norfolk
PE30 1HB

 

PHARM-SYS LTD

(Registration number: 12749673)
Statement of financial position as at 31 July 2023

2023
£

2022
£

Fixed assets

1,516

1,886

Current assets

13,541

16,027

Prepayments and accrued income

-

417

Creditors: Amounts falling due within one year

(1,065)

(1,569)

Net current assets

12,476

14,875

Total assets less current liabilities

13,992

16,761

Accruals and deferred income

(240)

-

 

13,752

16,761

Capital and reserves

13,752

16,761

1

General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
11 King's Street
Kings Lynn
Norfolk
PE30 1ET

These financial statements were authorised for issue by the Board on 18 April 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2022 - 2).

For the financial year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

 

PHARM-SYS LTD

(Registration number: 12749673)
Statement of financial position as at 31 July 2023

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Statement of comprehensive income.

Approved and authorised by the Board on 18 April 2024 and signed on its behalf by:
 

.........................................
Mr M R Jillings
Director